Eli Lilly CEO Ricks Says AHCA Won't Hurt Drug Prices

The transcript discusses changes in healthcare policy, focusing on the Affordable Care Act and its impact on drug prices and coverage. It highlights the shift of power from federal to state levels, allowing states to manage healthcare more effectively. The discussion also covers the potential effects of removing essential benefits and the implications for drug pricing. Additionally, the conversation touches on corporate tax reform and its potential impact on the pharmaceutical industry.

What is the speaker's perspective on the relationship between drug coverage costs and consumer demand?

What evidence does the speaker provide to support the argument that the current healthcare system is unsustainable?